Events featuring EHEN partners
HEDIMED aims to identifying exposomic determinants that can contribute to the ongoing epidemic of immune-mediated diseases focusing on type 1 diabetes, celiac disease, allergies, and asthma, all of which have increased rapidly over the past few decades. HEDIMED utilized extensive prospective sample and data series collected from pregnant women and children in large birth cohort studies and used modern molecular profiling and data mining tools to identify exposomic risk and protective factors. HEDIMED also created a toolbox that brings several new technologies and solutions available for various stakeholders.
During this stakeholder event, the HEDIMED team will present the key outcomes of the project and address scientific, technological and policy aspects of this research.
Key topics include:
- Exposomic insights into immune mediated diseases: risk factors, causes, mechanisms
- Common exposomic determinants of immune-mediated diseases
- Innovative technologies and platforms for exposome research
- Policy-related insights related to celiac disease, type 1 diabetes and allergies & asthma
& Panel discussion: “How exposomic insights can shape policies and public health”
You are warmly welcome to join us online for an inspiring day of learning about the exposome, its impact on immune-mediated diseases, and exchange perspectives with researchers and experts from HEDIMED consortium, as well as with other invited European stakeholders.
